Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, Feb. 4, 2015, 79 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $259.62 to $50,000,000.00.

Highlighted Stocks Traded by Insiders:

Berry Plastics Group (BERY) - FREE Research Report

Rich Jonathan D, who is Chief Executive Officer at Berry Plastics Group, sold 40,000 shares at $33.36 on Feb. 4, 2015. Following this transaction, the Chief Executive Officer owned 301,358 shares meaning that the stake was reduced by 11.72% with the 40,000-share transaction.

The shares most recently traded at $34.95, up $1.59, or 4.54% since the insider transaction. Historical insider transactions for Berry Plastics Group go as follows:

  • 4-Week # shares sold: 10,000
  • 12-Week # shares sold: 10,000
  • 24-Week # shares sold: 10,000

The average volume for Berry Plastics Group has been 1.4 million shares per day over the past 30 days. Berry Plastics Group has a market cap of $4.0 billion and is part of the consumer goods sector and consumer non-durables industry. Shares are up 10.14% year-to-date as of the close of trading on Wednesday.

Berry Plastics Group, Inc. manufactures and distributes plastic consumer packaging and engineered materials in North America and internationally. The company operates through four segments: Rigid Open Top, Rigid Closed Top, Engineered Materials, and Flexible Packaging. The company has a P/E ratio of 59.5. Currently, there are 7 analysts who rate Berry Plastics Group a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on BERY - FREE

TheStreet Quant Ratings rates Berry Plastics Group as a sell. The company's weaknesses can be seen in multiple areas, such as its poor profit margins and weak operating cash flow. Get the full Berry Plastics Group Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

St Jude Medical (STJ) - FREE Research Report

Murphy Mark W., who is VP, IT and CIO at St Jude Medical, sold 859 shares at $66.92 on Feb. 4, 2015. Following this transaction, the VP, IT and CIO owned 3,002 shares meaning that the stake was reduced by 22.25% with the 859-share transaction.

The shares most recently traded at $67.94, up $1.02, or 1.5% since the insider transaction. Historical insider transactions for St Jude Medical go as follows:

  • 4-Week # shares sold: 9,767
  • 12-Week # shares sold: 9,767
  • 24-Week # shares sold: 10,267

The average volume for St Jude Medical has been 2.0 million shares per day over the past 30 days. St Jude Medical has a market cap of $19.4 billion and is part of the health care sector and health services industry. Shares are up 2.31% year-to-date as of the close of trading on Wednesday.

St. Jude Medical, Inc. develops, manufactures and distributes medical devices for cardiac rhythm management, cardiovascular, and atrial fibrillation therapy areas worldwide. It operates in two divisions, Implantable Electronic Systems, and Cardiovascular and Ablation Technologies. The stock currently has a dividend yield of 1.6%. The company has a P/E ratio of 17.0. Currently, there are 15 analysts who rate St Jude Medical a buy, 1 analyst rates it a sell, and 5 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on STJ - FREE

TheStreet Quant Ratings rates St Jude Medical as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, impressive record of earnings per share growth, compelling growth in net income, notable return on equity and reasonable valuation levels. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. Get the full St Jude Medical Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Flexsteel Industries (FLXS) - FREE Research Report

Maricich Robert J, who is Director at Flexsteel Industries, bought 728 shares at $25.11 on Feb. 4, 2015. Following this transaction, the Director owned 14,120 shares meaning that the stake was boosted by 5.44% with the 728-share transaction.

The shares most recently traded at $30.37, up $5.26, or 17.31% since the insider transaction. Historical insider transactions for Flexsteel Industries go as follows:

  • 4-Week # shares bought: 1,705
  • 4-Week # shares sold: 8,611
  • 12-Week # shares bought: 1,705
  • 12-Week # shares sold: 8,611
  • 24-Week # shares bought: 1,705
  • 24-Week # shares sold: 29,321

The average volume for Flexsteel Industries has been 19,400 shares per day over the past 30 days. Flexsteel Industries has a market cap of $229.6 million and is part of the consumer goods sector and consumer durables industry. Shares are down 3.81% year-to-date as of the close of trading on Wednesday.

Flexsteel Industries, Inc., together with its subsidiaries, manufactures, imports, and markets residential and commercial upholstered and wood furniture products in the United States. The stock currently has a dividend yield of 2.32%. The company has a P/E ratio of 14.6. Currently, there are no analysts who rate Flexsteel Industries a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on FLXS - FREE

TheStreet Quant Ratings rates Flexsteel Industries as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, increase in stock price during the past year, growth in earnings per share, increase in net income and attractive valuation levels. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full Flexsteel Industries Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

null